← Open Payments lookup

JACOB KELTON: Open Payments

NPI 1730583840 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,112 in 53 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,193 · 2025 $1,112

Food & beverage: $1,111Education: $0
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.9$225
Bayer Healthcare Pharmaceuticals Inc.9$173
Boehringer Ingelheim Pharmaceuticals, Inc.10$162
AstraZeneca Pharmaceuticals LP7$115
Ardelyx, Inc.4$115
Fresenius USA Marketing, Inc.4$99
Novartis Pharmaceuticals Corporation2$77
Travere Therapeutics, Inc.3$58
Novo Nordisk Inc3$51
Amgen Inc.1$19

Products named: TARPEYO, Kerendia, JARDIANCE, FARXIGA, IBSRELA, VELPHORO, Fabhalta, Rybelsus.

Industry payments across TX — which companies pay providers there.